The Bleeding Patient

Sep 18, 2016 by in PHARMACY Comments Off on The Bleeding Patient

Fig. 24.1 Primary hemostasis, secondary hemostasis and the fibrinolytic pathway. FDP – fibrin degradation products Table 24.1 Causes of bleeding disorders Management of Haemorrhage In treating the acutely bleeding patient,…

read more

Dose Response Relationship

Sep 18, 2016 by in PHARMACY Comments Off on Dose Response Relationship

Note: G-protein-coupled receptors are also called metabotropic receptors The basic concept of drug-receptor (receptor is used loosely to mean the binding target) interaction can be described by the lock-and-key model,…

read more

Medication Errors

Sep 18, 2016 by in PHARMACY Comments Off on Medication Errors

Permission from Elsevier; the Journal of Emergency Medicine 2011;40(5):485–92 1. Prescribing This involves the assessment for the need to prescribe a drug and the selection of the said drug.  …

read more

Drugs and the Neuromuscular System

Sep 18, 2016 by in PHARMACY Comments Off on Drugs and the Neuromuscular System

Fig. 17.1 Structure of neuromuscular junction (With permission from Oxford University Press; Br J Anaesth CEPD Rev. 2002;2(5):129–33) The area of the nerve which lies closest to the muscle cell…

read more

The Obstetric Patient

Sep 18, 2016 by in PHARMACY Comments Off on The Obstetric Patient

Drugs Used During Pregnancy and Delivery Care providers use many drugs for different purposes during pregnancy and delivery. There are some drugs that are used to aid with the delivery…

read more

The Pediatric Patient

Sep 18, 2016 by in PHARMACY Comments Off on The Pediatric Patient

Fig. 20.1 Blood levels of a child exposed to doses of chloramphenicol calculated according to body weight (solid line) and blood levels in the child exposed to doses adjusted downwards…

read more

Drugs and the Respiratory System

Sep 18, 2016 by in PHARMACY Comments Off on Drugs and the Respiratory System

Mechanism of Action of β2 Agonists Activation of β2 receptors (β2AR) by β2 agonist results in activation of adenylyl cyclase (AC) via a stimulatory G protein (Gs). This leads to…

read more

Drugs and the Cardiovascular System

Sep 18, 2016 by in PHARMACY Comments Off on Drugs and the Cardiovascular System

Fig. 11.1 The mechanism by which catecholamine exerts its effects. Gs-GTP: Stimulating Guanosine nucleotide-binding protein-Guanosine Triphosphate complex; cAMP: cyclic Adenosine Monophosphate; Ca2+: Calcium; SR: sarcoplasmic reticulum (Reproduced with permission from…

read more

Drugs and the Renal System

Sep 18, 2016 by in PHARMACY Comments Off on Drugs and the Renal System

Chronic kidney disease is defined as either kidney damage or GFR < 60 ml/min/1.73m2 for 3 months. Kidney damage is defined as pathologic abnormalities or markers of damage, including abnormalities in blood, urine…

read more

Drug Interactions

Sep 18, 2016 by in PHARMACY Comments Off on Drug Interactions

Pharmacodynamic Interaction This occurs when the action or effect of a drug modulates that of another drug, producing a clinical response that differs from that anticipated from either drug when…

read more
Get Clinical Tree app for offline access